CareDx to Participate in Upcoming Conferences
Get Alerts CDNA Hot Sheet
Join SI Premium – FREE
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced today the Company plans to participate in the 2021 Wells Fargo Healthcare Conference and H.C. Wainwright 23rd Annual Global Investment Conference.
CareDx’s management will be participating in the 2021 Wells Fargo Healthcare Conference on Thursday, September 9, 2021 at 3:20 p.m Eastern Time. To listen to a live webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
CareDx’s management will be participating in the H.C. Wainwright 23rd Annual Global Investment Conference with a presentation available on Monday, September 13, 2021 at 7:00 a.m Eastern Time. To listen to the webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.
About CareDxCareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:CareDx, Inc.Sasha KingChief Marketing Officer415-287-2393[email protected]
Investor RelationsIan Cooney(415) 287-2300 x3550[email protected]
Source: CareDx, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electra Appoints Peter Rawlins as Chief Financial Officer; Reports Second Quarter 2026 Results
- Dimensional Fund Advisors Ltd. : Form 8.3 - GAMMA COMMUNICATIONS PLC - Ordinary Shares
- Novonesis launches Optiva® Triticum to help pasta manufacturers navigate wheat volatility without compromising quality
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Wells Fargo, H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share